Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remazolam Besylate in ICU Patients With Impaired Renal Function
NCT06153498Completed
- Start
- Nov 2023
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of remimazolam in mechanical ventilation (2 arms). Primary endpoints: Maximum Plasma Concentration at 24 hours, Area Under the Plasma Drug Concentration-Time Curve at 24 hours and 1 more. Started Nov 2023; status: completed.
02
Drugs
remimazolam
03
Conditions
mechanical ventilation
Beyond the preview
Go deeper on NCT06153498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06153498.